Home » Market News » DirectorsTalk Highlights » Another Tally Puts Autism Cases at 1 in 40
Oxford BioDynamics

Another Tally Puts Autism Cases at 1 in 40

Yet another study reveals that autism is far more common than once thought, with nearly 3% of American children diagnosed with the disorder.

A federal study published last week reported that one in 40 children have an autism spectrum disorder (ASD), and a second study that was published online Dec. 3 in the journal JAMA Pediatrics arrived at the same conclusion. Previously, it was estimated that one in 59 children have autism.

More troubling was that Dr. Wei Bao, lead researcher on the second study, found that 30 % of kids who are diagnosed are not receiving treatment.


Oxford BioDynamics Plc (LON: OBD)  is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.